Raymond James Financial

Raymond James Financial Portfolio holdings

AUM $290B
 

Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.

This Quarter Return
+10.68%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$290B
AUM Growth
+$24.8B
Cap. Flow
+$3.63B
Cap. Flow %
1.25%
Top 10 Hldgs %
21.86%
Holding
6,966
New
2,155
Increased
2,393
Reduced
2,166
Closed
46

Sector Composition

1 Technology 16.55%
2 Financials 9.27%
3 Industrials 6.89%
4 Healthcare 6.26%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SYRE icon
6576
Spyre Therapeutics
SYRE
$1.03B
$240 ﹤0.01%
+16
New +$240
INKT icon
6577
MiNK Therapeutics
INKT
$66.9M
$236 ﹤0.01%
+32
New +$236
BEEM icon
6578
Beam Global
BEEM
$44.7M
$235 ﹤0.01%
+161
New +$235
VVOS icon
6579
Vivos Therapeutics
VVOS
$30.9M
$234 ﹤0.01%
+74
New +$234
SER icon
6580
Serina Therapeutics
SER
$52.2M
$234 ﹤0.01%
+38
New +$234
VALN
6581
Valneva
VALN
$743M
$232 ﹤0.01%
+41
New +$232
MGX icon
6582
Metagenomi
MGX
$71.7M
$232 ﹤0.01%
+157
New +$232
PYPD icon
6583
PolyPid
PYPD
$54.8M
$229 ﹤0.01%
+65
New +$229
SBEV icon
6584
Splash Beverage Group
SBEV
$3.52M
$229 ﹤0.01%
+61
New +$229
BTAI icon
6585
BioXcel Therapeutics
BTAI
$55.2M
$226 ﹤0.01%
+125
New +$226
ZKIN icon
6586
ZK International Group
ZKIN
$9.55M
$225 ﹤0.01%
+109
New +$225
MYO icon
6587
Myomo
MYO
$37.7M
$222 ﹤0.01%
+103
New +$222
VRA icon
6588
Vera Bradley
VRA
$60.6M
$221 ﹤0.01%
+100
New +$221
VTAK icon
6589
Catheter Precision
VTAK
$3.03M
$220 ﹤0.01%
+48
New +$220
STHO icon
6590
Star Holdings Shares of Beneficial Interest
STHO
$116M
$219 ﹤0.01%
+28
New +$219
PMVP icon
6591
PMV Pharmaceuticals
PMVP
$77.4M
$212 ﹤0.01%
+200
New +$212
OM icon
6592
Outset Medical
OM
$249M
$211 ﹤0.01%
+11
New +$211
DLHC icon
6593
DLH Holdings
DLHC
$84.2M
$210 ﹤0.01%
+36
New +$210
ENSC icon
6594
Ensysce Biosciences
ENSC
$6.32M
$210 ﹤0.01%
+94
New +$210
SOND icon
6595
Sonder
SOND
$23.6M
$208 ﹤0.01%
+77
New +$208
MOBX icon
6596
Mobix Labs
MOBX
$58.2M
$204 ﹤0.01%
+266
New +$204
LUXE
6597
LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share
LUXE
$1.29B
$199 ﹤0.01%
+25
New +$199
OPI
6598
Office Properties Income Trust
OPI
$16.7M
$199 ﹤0.01%
+804
New +$199
STTK icon
6599
Shattuck Labs
STTK
$74.2M
$198 ﹤0.01%
+250
New +$198
CELU icon
6600
Celularity
CELU
$64.3M
$196 ﹤0.01%
+100
New +$196